The 5 most recent market catalysts affecting $ENSC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 14, 2026
Corporate Catalyst
Neutral
Impact 55
Watching Ensysce Biosciences; Zacks Small-Cap Research Gives Stock $8.25 Price Valuation
The headline's primary impact is on Ensysce Biosciences (ENSC) due to the specific price valuation. While a positive valuation from a research firm is generally bullish, Zacks Smal…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 75
Ensysce Biosciences shares are trading higher after the company received a U.S. patent notice titled "compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof."
This patent notice is a significant corporate catalyst for Ensysce Biosciences, as it strengthens their intellectual property portfolio in a potentially lucrative area. The 'compos…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 65
12 Health Care Stocks Moving In Monday's After-Market Session
The filing reports after-market trading activity for 12 healthcare stocks, highlighting both gainers and losers. For companies like Inspire Medical Systems (INSP), ClearPoint Neuro…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 75
Ensysce Biosciences shares are trading higher after the company received a notice of allowance for a U.S. patent titled "COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF"
The patent allowance for 'COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF' is a significant positive catalyst for Ensysce Biosciences (ENSC). T…
Aug 3, 2026
Corporate Catalyst
Neutral
Impact 65
Ensysce Biosciences Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF".
Ensysce Biosciences announced a Notice of Allowance for a U.S. patent covering 'COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF'. This is a pos…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.